Return to search

Shore Capital-backed Argentum Medical acquires Anacapa

Argentum Medical, which is backed by Shore Capital, has acquired San Dimas, California-based Anacapa Technologies, a provider of antimicrobial wound care products.

Argentum Medical, which is backed by Shore Capital, has acquired San Dimas, California-based Anacapa Technologies, a provider of antimicrobial wound care products. No financial terms were disclosed.

PRESS RELEASE

GENEVA, ILL. (PRWEB) JANUARY 18, 2022
Argentum Medical, a Shore Capital-backed medical device leader and pioneer of silver-plated nylon technology, today announced the acquisition of Anacapa Technologies’ antimicrobial wound cleansers, gels and irrigation product lines. Anacapa Technologies is a market leader and innovator in the formulation of antimicrobial wound care products. Argentum Medical acquired Anacapa Technologies to expand and enhance their wound-care portfolio with the addition of Anasept® and Silver-Sept® product lines. The transaction was completed on December 29, 2021.

Argentum Medical already provides a leading wound-care portfolio, consisting of Silverlon® antimicrobial silver-plated nylon dressings and TheraBond 3D® wound, surgical site and burn care dressings. To complement its current product portfolio, Argentum Medical will integrate Anacapa Technologies’ Anasept® and Silver-Sept® antimicrobial wound cleansers, gels and irrigation solutions with its current wound-care offering (all brand names will remain the same):

Argentum Medical Current Portfolio
Silverlon wound care dressings are critical in helping to prevent infection in surgical, wound or burn victims. Silverlon antimicrobial silver-plated dressings have 50 to 100 times more metallic silver ions than other silver-impregnated dressings. Multiple, peer-reviewed, published clinical studies show the significant benefits of Silverlon in a wide variety of wound settings, including surgical, negative pressure, burn, skin graft, and IV and catheter-related wounds.

TheraBond 3D wound care controls bioburden and minimizes maceration, TheraBond 3D surgical site care provides antimicrobial protection in a variety of post-op scenarios, and TheraBond 3D burn care utilizes unique capillary-like technology to transfer excess fluid away from burns to an outer absorbent dressing.

Argentum Medical Acquired Portfolio
Anasept antimicrobial wound cleanser, gel and irrigation solution helps in the mechanical removal of debris, while delivering broad-spectrum antimicrobial to wound site to inhibit bacteria growth.
Silver-Sept antimicrobial skin and wound gel that inhibits the growth of bacteria and helps maintain a moist wound environment conducive to healing.

With this portfolio, Argentum Medical provides clinicians with an extensive range of solutions for the management of wounds, surgical sites and burns to improve patient outcomes.

“The acquisition of Anacapa Technologies’ wound care solutions continues our strategy to innovate patient care with the most sophisticated technologies and expand our growth in the wound-care space,” said Raul Brizuela, president and CEO of Argentum Medical. “We are excited that Anacapa Technologies is now a part of the Argentum Medical/Cura Surgical family.”

Argentum Medical manufactures its products in the U.S. and will continue to market and distribute all its products domestically and internationally.

“I am proud that Argentum Medical will become the home for our innovations, and by joining forces, together we will help shape the future of wound-care,” said Wally Rogozinski, CEO and inventor of Anacapa Technologies’ core products. “I look forward to seeing this innovative portfolio of products help patients and clinicians globally as part of Argentum Medical.”

Anacapa Technologies is headquartered in San Dimas, California. Upon completion of the transaction, Anacapa Technologies wound care solutions will become part of Argentum Medical.

ABOUT SILVERLON
SILVERLON® wound dressings have a permanently plated metallic surface, which provides the antimicrobial benefits of silver in the dressing without staining the skin and without increasing bioburden. SILVERLON® was originally developed for the U.S. military, where it is still extensively used for management of burn and blast injuries. SILVERLON® dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds. For more, visit Silverlon.com